Related Experiment Videos
Elevated nitric oxide production mediates beta-amyloid-induced mitochondria failure
U Keil1, A Bonert, C A Marques
1Department of Pharmacology, Biocenter, University of Frankfurt, 60439 Frankfurt/Main, Germany.
Polish Journal of Pharmacology
|December 14, 2004
Summary
Alzheimer's disease (AD) involves mitochondrial dysfunction and nitric oxide (NO). This study shows the Swedish mutation in amyloid precursor protein (APPsw) increases NO, impairing mitochondrial function and ATP production in cells.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Mitochondrial dysfunction is a hallmark of neurodegenerative diseases like Alzheimer's disease (AD).
- Nitric oxide (NO) plays a role in AD pathogenesis.
- Investigating the link between amyloid precursor protein (APP) mutations, NO, and mitochondrial health is crucial for understanding AD.
Framework:
- This study utilizes PC12 cell lines as a model system.
- The Swedish mutation (APPsw) in APP was introduced to mimic aspects of AD pathology.
- Comparisons were made between APPsw-transfected cells, wild-type APP cells, and empty vector controls.
Implementation:
- APPsw PC12 cells were analyzed for nitric oxide (NO) levels.
- Mitochondrial function was assessed by measuring cytochrome C oxidase activity.
- Cellular energy status was evaluated through ATP level quantification.
Implications:
- APPsw expression leads to elevated NO levels in PC12 cells.
- Impaired mitochondrial function, evidenced by reduced cytochrome C oxidase activity and ATP levels, is observed in APPsw cells.
- These findings suggest a pathway where amyloid-beta peptide and NO production contribute to mitochondrial failure in AD.